In this interview with Foundation board member, Dr. Honorine Ward (Batch ’69), Dr. Gagandeep “Cherry” Kang (Batch ’81) speaks to the significance of her recent recognition, how the Jawadhi Hills model program can serve as a model for underserved populations, and CMC’s COVID-19 response.
ABOUT DR. GAGANDEEP KANG
Gagandeep “Cherry” Kang is a clinician scientist and professor in the department of Gastrointestinal Sciences at CMC. Dr. Kang completed her undergraduate, postgraduate, and PhD graduate training at CMC, and joined the faculty after. She recently returned to CMC after serving as the executive director of the Translational Health Science and Technology Institute, an institute of the Government of India. Dr. Kang has received national and international recognition for her work with childhood gastrointestinal infections and the testing of rotaviral vaccines. She serves as the Chair of the World Health Organization’s (WHO’s)Technical Advisory Group on Immunization for the Southeast Asian region, and she is also on the WHO advisory committee for vaccine development. Dr. Kang was awarded the prestigious Infosys Prize in Life Sciences in 2016 for her contributions to understanding rotavirus and other infectious diseases. In 2019, Dr. Kang became the first Indian woman to be elected as a Fellow of the Royal Society of London — an honor for her, CMC, and India.